NYSE:MD - New York Stock Exchange, Inc. - US58502B1061 - Common Stock - Currency: USD
14.33
-0.15 (-1.04%)
The current stock price of MD is 14.33 USD. In the past month the price increased by 9.22%. In the past year, price increased by 43.01%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 10.34 | 82.91B | ||
CI | THE CIGNA GROUP | 9.79 | 73.44B | ||
LH | LABCORP HOLDINGS INC | 17.56 | 22.04B | ||
DGX | QUEST DIAGNOSTICS INC | 18.71 | 19.79B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.75 | 14.12B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 98.55 | 12.86B | ||
HIMS | HIMS & HERS HEALTH INC | 64.93 | 11.63B | ||
DVA | DAVITA INC | 13.36 | 9.78B | ||
GH | GUARDANT HEALTH INC | N/A | 6.72B | ||
CHE | CHEMED CORP | 19.46 | 6.37B | ||
OPCH | OPTION CARE HEALTH INC | 20.89 | 4.62B | ||
CRVL | CORVEL CORP | 47.36 | 4.43B |
Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,150 full-time employees. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. The company offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. The company provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The firm provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
PEDIATRIX MEDICAL GROUP INC
1301 Concord Terrace
Sunrise FLORIDA 33323 US
CEO: Mark S. Ordan
Employees: 4120
Phone: 19543840175
The current stock price of MD is 14.33 USD. The price decreased by -1.04% in the last trading session.
The exchange symbol of PEDIATRIX MEDICAL GROUP INC is MD and it is listed on the New York Stock Exchange, Inc. exchange.
MD stock is listed on the New York Stock Exchange, Inc. exchange.
16 analysts have analysed MD and the average price target is 17.49 USD. This implies a price increase of 22.02% is expected in the next year compared to the current price of 14.33. Check the PEDIATRIX MEDICAL GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PEDIATRIX MEDICAL GROUP INC (MD) has a market capitalization of 1.23B USD. This makes MD a Small Cap stock.
PEDIATRIX MEDICAL GROUP INC (MD) currently has 4120 employees.
PEDIATRIX MEDICAL GROUP INC (MD) has a support level at 14.32 and a resistance level at 15.02. Check the full technical report for a detailed analysis of MD support and resistance levels.
The Revenue of PEDIATRIX MEDICAL GROUP INC (MD) is expected to decline by -6.17% in the next year. Check the estimates tab for more information on the MD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MD does not pay a dividend.
PEDIATRIX MEDICAL GROUP INC (MD) will report earnings on 2025-10-30, before the market open.
The PE ratio for PEDIATRIX MEDICAL GROUP INC (MD) is 7.92. This is based on the reported non-GAAP earnings per share of 1.81 and the current share price of 14.33 USD. Check the full fundamental report for a full analysis of the valuation metrics for MD.
The outstanding short interest for PEDIATRIX MEDICAL GROUP INC (MD) is 2.42% of its float. Check the ownership tab for more information on the MD short interest.
ChartMill assigns a technical rating of 6 / 10 to MD. When comparing the yearly performance of all stocks, MD is one of the better performing stocks in the market, outperforming 79.86% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to MD. MD has an average financial health and profitability rating.
Over the last trailing twelve months MD reported a non-GAAP Earnings per Share(EPS) of 1.81. The EPS increased by 53.39% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -4.13% | ||
ROE | -10.44% | ||
Debt/Equity | 0.75 |
ChartMill assigns a Buy % Consensus number of 79% to MD. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 15.09% and a revenue growth -6.17% for MD